{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:12:43Z","timestamp":1790946763367,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12350-018-1395-4","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T12:24:54Z","timestamp":1534249494000},"page":"269-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy"],"prefix":"10.1016","volume":"27","author":[{"given":"Kuan-Yin","family":"Ko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoh-Fang","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chien","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yuan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Lin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Ming","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-018-1395-4_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02990019","article-title":"Myocardial viability assessment using nuclear imaging","volume":"17","author":"Matsunari","year":"2003","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-018-1395-4_bib2","first-page":"565","article-title":"The clinical role of metabolic imaging of the heart by positron emission tomography","volume":"32","author":"Schwaiger","year":"1991","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1395-4_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01728306","article-title":"Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols","volume":"24","author":"Bax","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"10.1007\/s12350-018-1395-4_bib4","first-page":"1499","article-title":"Reverse flow-metabolism mismatch: What does it mean?","volume":"40","author":"Schwaiger","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1395-4_bib5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1139\/m89-069","article-title":"Distribution of spermine in bacilli and lactic acid bacteria","volume":"35","author":"Hamana","year":"1989","journal-title":"Can J Microbiol"},{"key":"10.1007\/s12350-018-1395-4_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCIMAGING.109.853291","article-title":"In vivo assessment of myocardial glucose uptake by positron emission tomography in adults with the PRKAG2 cardiac syndrome","volume":"2","author":"Ha","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-1395-4_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj1860701","article-title":"Utilization of energy-providing substrates in the isolated working rat heart","volume":"186","author":"Taegtmeyer","year":"1980","journal-title":"Biochem J"},{"key":"10.1007\/s12350-018-1395-4_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.RES.0000137170.41939.d9","article-title":"Is the failing heart energy starved? On using chemical energy to support cardiac function","volume":"95","author":"Ingwall","year":"2004","journal-title":"Circ Res"},{"key":"10.1007\/s12350-018-1395-4_bib9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/hrt.2009.190256","article-title":"Modification of myocardial substrate utilisation: A new therapeutic paradigm in cardiovascular disease","volume":"96","author":"Beadle","year":"2010","journal-title":"Heart"},{"key":"10.1007\/s12350-018-1395-4_bib10","doi-asserted-by":"crossref","first-page":"H1917","DOI":"10.1152\/ajpheart.00687.2010","article-title":"Myocardial insulin resistance induced by high fat feeding in heart failure is associated with preserved contractile function","volume":"299","author":"Christopher","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1007\/s12350-018-1395-4_bib11","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2337\/db11-1805","article-title":"Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans","volume":"61","author":"Labbe","year":"2012","journal-title":"Diabetes"},{"key":"10.1007\/s12350-018-1395-4_bib12","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1172\/JCI118742","article-title":"Mechanism of free fatty acid-induced insulin resistance in humans","volume":"97","author":"Roden","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1007\/s12350-018-1395-4_bib13","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/01.CIR.0000139340.88769.D5","article-title":"Cardiac metabolism as a target for the treatment of heart failure","volume":"110","author":"Taegtmeyer","year":"2004","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-1395-4_bib14","doi-asserted-by":"crossref","DOI":"10.1007\/s10741-017-9665-9","article-title":"Direct cardiovascular impact of SGLT2 inhibitors: Mechanisms and effects","author":"Kaplan","year":"2018","journal-title":"Heart Fail Rev"},{"key":"10.1007\/s12350-018-1395-4_bib15","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db16-0733","article-title":"The sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents cardiomyopathy in a diabetic lipodystrophic mouse model","volume":"66","author":"Joubert","year":"2017","journal-title":"Diabetes"},{"key":"10.1007\/s12350-018-1395-4_bib16","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/CIRCRESAHA.116.305665","article-title":"DPP4 in cardiometabolic disease: Recent insights from the laboratory and clinical trials of DPP4 inhibition","volume":"116","author":"Zhong","year":"2015","journal-title":"Circ Res"},{"key":"10.1007\/s12350-018-1395-4_bib17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/CIRCRESAHA.117.311588","article-title":"Cardiovascular effects of new oral glucose-lowering agents: DPP-4 and SGLT-2 inhibitors","volume":"122","author":"Scheen","year":"2018","journal-title":"Circ Res"},{"key":"10.1007\/s12350-018-1395-4_bib18","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-1395-4_bib19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1007\/s12350-018-1395-4_bib20","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes","volume":"70","author":"Shah","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-1395-4_bib21","first-page":"400","article-title":"TSOC-HFrEF registry: A registry of hospitalized patients with decompensated systolic heart failure: Description of population and management","volume":"32","author":"Wang","year":"2016","journal-title":"Acta Cardiol Sin"},{"key":"10.1007\/s12350-018-1395-4_bib22","first-page":"127","article-title":"One-year outcomes of acute decompensated systolic heart failure in Taiwan: Lessons from TSOC-HFrEF registry","volume":"33","author":"Chang","year":"2017","journal-title":"Acta Cardiol Sin"},{"key":"10.1007\/s12350-018-1395-4_bib23","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1038\/s41598-018-22213-z","article-title":"Mechanical dyssynchrony and diastolic dysfunction are common in LVH: a pilot correlation study using Doppler echocardiography and CZT gated-SPECT MPI","volume":"8","author":"Tsai","year":"2018","journal-title":"Sci Rep"},{"key":"10.1007\/s12350-018-1395-4_bib24","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s00259-010-1488-z","article-title":"A fast cardiac gamma camera with dynamic SPECT capabilities: Design, system validation and future potential","volume":"37","author":"Bocher","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-1395-4_bib25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12350-014-9963-8","article-title":"Data-driven respiratory motion tracking and compensation in CZT cameras: A comprehensive analysis of phantom and human images","volume":"22","author":"Ko","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-1395-4_bib26","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/j.nuclcard.2006.08.009","article-title":"Positron emission tomography myocardial perfusion and glucose metabolism imaging","volume":"13","author":"Machac","year":"2006","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-1395-4_bib27","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0735-1097(99)00010-8","article-title":"Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction","volume":"33","author":"Schoder","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-1395-4_bib28","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-1395-4_bib29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ehj.2004.03.012","article-title":"Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology","volume":"25","author":"Underwood","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-018-1395-4_bib30","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/01.CIR.93.9.1658","article-title":"Glucose uptake in the chronically dysfunctional but viable myocardium","volume":"93","author":"Maki","year":"1996","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-1395-4_bib31","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1006\/jmcc.1997.0405","article-title":"Persistent myocardial ischemia increases GLUT1 glucose transporter expression in both ischemic and non-ischemic heart regions","volume":"29","author":"Brosius","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"10.1007\/s12350-018-1395-4_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.RES.0000138301.42713.18","article-title":"Program of cell survival underlying human and experimental hibernating myocardium","volume":"95","author":"Depre","year":"2004","journal-title":"Circ Res"},{"key":"10.1007\/s12350-018-1395-4_bib33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00259-012-2311-9","article-title":"Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy","volume":"40","author":"Zhang","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-1395-4_bib34","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/01.CIR.0000012466.50373.E8","article-title":"Adaptation and maladaptation of the heart in diabetes: Part I: General concepts","volume":"105","author":"Taegtmeyer","year":"2002","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-1395-4_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11010-005-9030-5","article-title":"Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: Role of sarcolemmal substrate transporters","volume":"299","author":"Coort","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1007\/s12350-018-1395-4_bib36","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2967\/jnumed.108.051672","article-title":"Time course of alterations in myocardial glucose utilization in the Zucker diabetic fatty rat with correlation to gene expression of glucose transporters: A small-animal PET investigation","volume":"49","author":"Shoghi","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1395-4_bib37","doi-asserted-by":"crossref","first-page":"E1049","DOI":"10.1152\/ajpendo.00560.2009","article-title":"Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats","volume":"298","author":"Menard","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1007\/s12350-018-1395-4_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11307-008-0171-2","article-title":"Mechanism of reduced myocardial glucose utilization during acute hypertriglyceridemia in rats","volume":"11","author":"Menard","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1007\/s12350-018-1395-4_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-med-050214-013431","article-title":"Cardiovascular effects of incretin-based therapies","volume":"67","author":"White","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1007\/s12350-018-1395-4_bib40","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1007\/s12350-018-1395-4_bib41","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jacc.2016.12.018","article-title":"Effect of linagliptin on arterial (18)F-fluorodeoxyglucose positron emission tomography uptake: A randomized controlled trial (RELEASE)","volume":"69","author":"de Boer","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-1395-4_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11897-014-0232-6","article-title":"Incretin-related drug therapy in heart failure","volume":"12","author":"Vest","year":"2015","journal-title":"Curr Heart Fail Rep"},{"key":"10.1007\/s12350-018-1395-4_bib43","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.117.028136","article-title":"Cardiovascular actions and clinical outcomes with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"136","author":"Nauck","year":"2017","journal-title":"Circulation"},{"key":"10.1007\/s12350-018-1395-4_bib44","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00259-002-0827-0","article-title":"Low whole-body insulin sensitivity in patients with ischaemic heart disease is associated with impaired myocardial glucose uptake predictive of poor outcome after revascularisation","volume":"29","author":"Kofoed","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-1395-4_bib45","doi-asserted-by":"crossref","first-page":"C710","DOI":"10.1152\/ajpcell.00137.2016","article-title":"sFRP2 activates Wnt\/beta-catenin signaling in cardiac fibroblasts: Differential roles in cell growth, energy metabolism, and extracellular matrix remodeling","volume":"311","author":"Lin","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1007\/s12350-018-1395-4_bib46","first-page":"632","article-title":"Association of uterine and salpingeal fibrosis with chlamydial hsp60 and hsp10 antigen-specific antibodies in Chlamydia-infected koalas","volume":"12","author":"Higgins","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1007\/s12350-018-1395-4_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-5-15","article-title":"Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease","volume":"5","author":"Fan","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1007\/s12350-018-1395-4_bib48","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MNM.0b013e3282f5d2bc","article-title":"Myocardial scar and insulin resistance predict cardiovascular events in severe ischaemic myocardial dysfunction: A perfusion-metabolism positron emission tomography study","volume":"29","author":"Feola","year":"2008","journal-title":"Nucl Med Commun"},{"key":"10.1007\/s12350-018-1395-4_bib49","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-1395-4_bib50","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jacc.2005.06.057","article-title":"The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction","volume":"46","author":"Desideri","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-1395-4_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0008-6363(99)00278-3","article-title":"Glucose metabolism in reperfused myocardium measured by [2-18F] 2-fluorodeoxyglucose and PET","volume":"45","author":"Kofoed","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1007\/s12350-018-1395-4_bib52","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/0735-1097(94)90744-7","article-title":"Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease","volume":"23","author":"Perrone-Filardi","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-1395-4_bib53","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s12350-011-9389-5","article-title":"Altered myocardial glucose utilization and the reverse mismatch pattern on rubidium-82 perfusion\/F-18-FDG PET during the sub-acute phase following reperfusion of acute anterior myocardial infarction","volume":"18","author":"Anselm","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-1395-4_bib54","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s002590100482","article-title":"PET \u201creversed mismatch pattern\u201d early after acute myocardial infarction: Follow-up of flow, metabolism and function","volume":"28","author":"Mesotten","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1007\/s12350-018-1395-4_bib55","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00259-013-2423-x","article-title":"Reverse blood flow-glucose metabolism mismatch indicates preserved oxygen metabolism in patients with revascularised myocardial infarction","volume":"40","author":"Fukuoka","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-1395-4_bib56","first-page":"1492","article-title":"A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction","volume":"40","author":"Yamagishi","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1395-4_bib57","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s12350-010-9228-0","article-title":"An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy","volume":"17","author":"Fallavollita","year":"2010","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-018-1395-4_bib58","first-page":"1255","article-title":"Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography","volume":"33","author":"Knuuti","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1395-4_bib59","first-page":"2064","article-title":"Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography","volume":"34","author":"Voipio-Pulkki","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1395-4_bib60","first-page":"456","article-title":"Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET","volume":"36","author":"Ohtake","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1395-4_bib61","first-page":"1730","article-title":"Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction","volume":"42","author":"Vitale","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-1395-4_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcma.2018.01.001","article-title":"2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases","author":"Chiang","year":"2018","journal-title":"J Chin Med Assoc"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-1395-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-018-1395-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123017658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123017658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-1395-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:07:41Z","timestamp":1761026861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123017658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1071358123017658"],"URL":"https:\/\/doi.org\/10.1007\/s12350-018-1395-4","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-018-1395-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}